|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1996)) |
IUPAC Name ![]() |
| (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5530 | acitretin |
Synonyms ![]() |
| Ro-101670000 |
| Soriatane® |
Database Links ![]() |
|
| CAS Registry No. | 55079-83-9 |
| ChEMBL Ligand | CHEMBL1131 |
| DrugBank Ligand | DB00459 |
| PubChem CID | 5284513 |
| Search Google for chemical match using the InChIKey | IHUNBGSDBOWDMA-AQFIFDHZSA-N |
| Search Google for chemicals with the same backbone | IHUNBGSDBOWDMA |
| Search PubMed clinical trials | acitretin |
| Search PubMed titles | acitretin |
| Search PubMed titles/abstracts | acitretin |
| Wikipedia | Acitretin |
| Comments |
| Acitretin is a second generation retinoid drug. Acitretin is an active metabolite of etretinate, but may also be reverse metabolised back to etretinate. |